Learning from the slime mold: Dictyostelium and human disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Dictyostelium discoideum as a non-mammalian biomedical model.Microbial biotechnology · 2021
   Review
2. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum.Infection and immunity · 2003
   Article
3. Crawling into a new era-the Dictyostelium genome project.The EMBO journal · 2003
   Review
4. Periventricular heterotopia and the genetics of neuronal migration in the cerebral cortex.American journal of human genetics · 1999
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as